FIELD: medicine; pharmaceutics.
SUBSTANCE: application describes planar dosage forms disintegrating or dissolving in an aqueous medium, intended for releasing at least one active substance in a natural opening or body cavities formed from a polymer matrix in the form of hardened foam having hollow spaces, as well as at least one pharmaceutical active substance and having a high weight per unit area of 150 to 220 g/m2. Application also describes methods for preparing said dosage form.
EFFECT: said dosage forms, despite the high weight per unit area and the resulting high dosage of the active substance during use, are characterized by a much better mouthfeel compared to conventional film dosage forms.
17 cl, 1 dwg, 1 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
FOAMED LOZENGE CONTAINING GRAFTED COPOLYMER OF POLYVINYL ALCOHOL AND POLYETHYLENE GLYCOL | 2006 |
|
RU2437648C2 |
METHOD OF PRODUCTION OF ORAL THIN FILM CONTAINING MICROPARTICLES | 2021 |
|
RU2811825C1 |
COMPRESSED PHARMACEUTICAL PRODUCT | 2016 |
|
RU2744270C2 |
UNSPITTABLE QUICKLY DECOMPOSING NEUROLEPTIC-CONTAINING FILM FOR ORAL APPLICATION | 2006 |
|
RU2427374C2 |
POCKET-SHAPED ORAL SOLUBLE FILMS WITH HIGH ACTIVE SUBSTANCE LOAD | 2018 |
|
RU2742415C1 |
BIODEGRADABLE SYSTEM OF TRANSMUCOSAL DELIVERY OF DROTAVERIN | 2017 |
|
RU2699808C2 |
ORAL THIN FILM WITH HIGH ACTIVE SUBSTANCE LOADING | 2018 |
|
RU2754824C1 |
TRANSBUCCAL DELIVERY SYSTEM | 1997 |
|
RU2192245C2 |
SOLID VETERINARY COMPOSITIONS WITH MASKED TASTE | 2003 |
|
RU2318498C2 |
DOSAGE FORM PROTECTED FROM UNINTENDED USE AND CONTAINING (1R, 2R)-3-(3-DIMETHYLAMINO-1-ETHYL-2-METHYLPROPYL)PHENOL | 2005 |
|
RU2393847C2 |
Authors
Dates
2024-09-12—Published
2018-06-07—Filed